Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002022176-24-000002
Filing Date
2024-05-07
Accepted
2024-05-07 14:03:14
Documents
1
Effectiveness Date
2024-05-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5742
  Complete submission text file 0002022176-24-000002.txt   6842
Mailing Address 65 WILLIAM STREET SUITE 200 WELLESLEY MA 02481
Business Address 65 WILLIAM STREET SUITE 200 WELLESLEY MA 02481 617-225-7700
Atacama Therapeutics, Inc. (Filer) CIK: 0002022176 (see all company filings)

EIN.: 814057067 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-512480 | Film No.: 24921104